Study Stopped
Due to unforeseen changes in study personnel, the study was not initiated.
Shared Decision Making in Low Risk Prostate Cancer
Shared Decision Making: A Study Assessing the Benefit of a Web Based Aid Presenting Treatment Options for Patients With Low Risk Prostate Cancer
1 other identifier
observational
N/A
1 country
1
Brief Summary
This study will evaluate the usefulness of an informational website designed to educate patients with prostate cancer about their options for treatment. The investigators hope that this website will assist patients with making informed decisions about their care and improving their satisfaction with the treatments they choose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 15, 2012
CompletedFirst Posted
Study publicly available on registry
August 28, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2020
CompletedMay 15, 2026
May 1, 2026
7.8 years
August 15, 2012
May 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient knowledge regarding the available treatment options for low-risk prostate cancer and their potential side effects.
Investigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.
2 years
Secondary Outcomes (4)
Decisional conflict and informed decision making experienced by patients.
2 years
Patient health related worry.
2 years
Patient views on cancer control for their treatment choice.
2 years
Patient satisfaction with their treatment choice.
2 years
Study Arms (1)
Low risk prostate cancer
Interventions
Eligibility Criteria
Low risk prostate cancer patients seen wthin the Claire \& John Bertucci Center for Genitourinary Cancers multidisciplinary clinic at MGH.
You may qualify if:
- Histologically confirmed prostate adenocarcinoma
- Internet access
- Able to read and understand English
You may not qualify if:
- Evidence of nodal metastases
- Evidence of distant metastases
- Prior surgery, chemotherapy, pelvic radiation or prostate brachytherapy for prostate cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason A. Efstathiou, MD, DPhil
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 15, 2012
First Posted
August 28, 2012
Study Start
August 1, 2012
Primary Completion
June 5, 2020
Study Completion
June 5, 2020
Last Updated
May 15, 2026
Record last verified: 2026-05